Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Arvinas Inc (ARVN)

Arvinas Inc (ARVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,923,277
  • Shares Outstanding, K 68,713
  • Annual Sales, $ 78,500 K
  • Annual Income, $ -367,300 K
  • EBIT $ -357 M
  • EBITDA $ -366 M
  • 60-Month Beta 1.96
  • Price/Sales 23.55
  • Price/Cash Flow N/A
  • Price/Book 3.15

Options Overview Details

View History
  • Implied Volatility 85.03% ( +2.32%)
  • Historical Volatility 42.49%
  • IV Percentile 88%
  • IV Rank 38.46%
  • IV High 125.27% on 11/13/23
  • IV Low 59.89% on 05/01/24
  • Put/Call Vol Ratio 0.05
  • Today's Volume 102
  • Volume Avg (30-Day) 124
  • Put/Call OI Ratio 0.96
  • Today's Open Interest 6,775
  • Open Int (30-Day) 6,771

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -1.18
  • Number of Estimates 11
  • High Estimate -0.33
  • Low Estimate -1.87
  • Prior Year -2.53
  • Growth Rate Est. (year over year) +53.36%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.26 +14.39%
on 10/10/24
29.61 -6.28%
on 10/30/24
+2.46 (+9.73%)
since 10/07/24
3-Month
23.61 +17.53%
on 08/14/24
29.61 -6.28%
on 10/30/24
+3.38 (+13.87%)
since 08/07/24
52-Week
14.02 +97.87%
on 11/10/23
53.08 -47.72%
on 02/16/24
+9.96 (+55.99%)
since 11/07/23

Most Recent Stories

More News
Arvinas to Participate in Upcoming Investor Conferences

ARVN : 27.75 (-0.86%)
Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update

ARVN : 27.75 (-0.86%)
Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day

ARVN : 27.75 (-0.86%)
Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024

ARVN : 27.75 (-0.86%)
OSI: Fiscal Q4 Earnings Snapshot

OSI: Fiscal Q4 Earnings Snapshot

ARVN : 27.75 (-0.86%)
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 1.0700 (-4.46%)
ICCM : 0.7399 (-9.78%)
ATOS : 1.5000 (+1.35%)
ARVN : 27.75 (-0.86%)
PFE : 27.46 (+0.37%)
ONC.TO : 1.50 (-3.23%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 1.0700 (-4.46%)
ONC.TO : 1.50 (-3.23%)
ICCM : 0.7399 (-9.78%)
ATOS : 1.5000 (+1.35%)
ARVN : 27.75 (-0.86%)
PFE : 27.46 (+0.37%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

ONCY : 1.0700 (-4.46%)
ONC.TO : 1.50 (-3.23%)
PFE : 27.46 (+0.37%)
ARVN : 27.75 (-0.86%)
OLMA : 12.40 (-0.96%)
AZN : 64.69 (+1.32%)
How Recent Biotech Breakthroughs Are Changing the Fight Against Breast Cancer

USA News Group – More people are getting breast cancer this year. Around 300,000 women and 2,800 men will find out they have it. While 1 out of every 8 women will hear they have breast cancer sometime...

AVRN : 0.0125 (-30.56%)
ONCY : 1.0700 (-4.46%)
ONC.TO : 1.50 (-3.23%)
PFE : 27.46 (+0.37%)
ARVN : 27.75 (-0.86%)
OLMA : 12.40 (-0.96%)
AZN : 64.69 (+1.32%)
Arvinas and Quantum Leap Healthcare Announce Clinical Study to Evaluate Vepdegestrant (ARV-471) in I-SPY-2 Endocrine Optimization Platform (EOP) Clinical Trial

/PRNewswire/ -- Arvinas, Inc. (Nasdaq: ARVN) and Quantum Leap Healthcare Collaborative™ today announced that Arvinas' vepdegestrant (ARV-471), a novel PROTAC®...

ARVN : 27.75 (-0.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Arvinas Inc. is a biopharmaceutical company for patients suffering from debilitating and life-threatening diseases. It engages in the discovery, development and commercialization of therapies to degrade disease-causing proteins. Arvinas Inc. is based in CT, United States.

See More

Key Turning Points

3rd Resistance Point 29.66
2nd Resistance Point 29.21
1st Resistance Point 28.48
Last Price 27.75
1st Support Level 27.30
2nd Support Level 26.84
3rd Support Level 26.11

See More

52-Week High 53.08
Fibonacci 61.8% 38.16
Fibonacci 50% 33.55
Fibonacci 38.2% 28.94
Last Price 27.75
52-Week Low 14.02

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar